Search research articles
Contact Us
Filters
Showing results (91-100 of 128) with videos related to
Page
of 13
Sort By:
Endocrine Journal
|
April 24, 2024
Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study)
Sho Furusawa, Hiroshi Nomoto, Chiho Oba-Yamamoto, et al.
Journal of Medicinal Chemistry
|
May 31, 2012
Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors
Takayoshi Suzuki, Mohammed Naseer Ahmed Khan, Hideyuki Sawada, et al.
Nature Communications
|
September 5, 2020
In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix
Jiyoung Lee, Akito Sutani, Rin Kaneko, et al.
Bioorganic & Medicinal Chemistry
|
March 25, 2015
Discovery of a potent, orally available dual CysLT₁ and CysLT₂ antagonist with dicarboxylic acid
Satoshi Itadani, Shinya Takahashi, Masaki Ima, et al.
Acta Ophthalmologica
|
January 31, 2019
Silicone oil-associated retinal light exposure under a surgical microscope
Kazuhisa Yamada, Hiroki Kaneko, Taichi Tsunekawa, et al.
BMJ Open
|
February 9, 2020
Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study
Reina Kameda, Hiroshi Nomoto, Kyu Yong Cho, et al.
Journal of Diabetes Investigation
|
May 17, 2021
Dipeptidyl peptidase-4 inhibitor might exacerbate Graves' disease: A multicenter observational case-control study
Tomonori Sekizaki, Hiraku Kameda, Hiroshi Nomoto, et al.
BMJ Open Diabetes Research & Care
|
November 15, 2022
Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study)
Hiroshi Nomoto, Akihiro Takahashi, Akinobu Nakamura, et al.
Japanese Journal of Ophthalmology
|
May 10, 2025
Factors predictive of treatment outcomes in submacular hemorrhage secondary to age-related macular degeneration
Yuto Watanabe, Takashi Koto, Aya Takahashi, et al.
Cancer Research
|
October 4, 2018
HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNA
Wenwen Wu, Nana Rokutanda, Jun Takeuchi, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 128) with videos related to
Sort By:
Page
of 13
Endocrine Journal
|
April 24, 2024
Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study)
Sho Furusawa, Hiroshi Nomoto, Chiho Oba-Yamamoto, et al.
Journal of Medicinal Chemistry
|
May 31, 2012
Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors
Takayoshi Suzuki, Mohammed Naseer Ahmed Khan, Hideyuki Sawada, et al.
Nature Communications
|
September 5, 2020
In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix
Jiyoung Lee, Akito Sutani, Rin Kaneko, et al.
Bioorganic & Medicinal Chemistry
|
March 25, 2015
Discovery of a potent, orally available dual CysLT₁ and CysLT₂ antagonist with dicarboxylic acid
Satoshi Itadani, Shinya Takahashi, Masaki Ima, et al.
Acta Ophthalmologica
|
January 31, 2019
Silicone oil-associated retinal light exposure under a surgical microscope
Kazuhisa Yamada, Hiroki Kaneko, Taichi Tsunekawa, et al.
BMJ Open
|
February 9, 2020
Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study
Reina Kameda, Hiroshi Nomoto, Kyu Yong Cho, et al.
Journal of Diabetes Investigation
|
May 17, 2021
Dipeptidyl peptidase-4 inhibitor might exacerbate Graves' disease: A multicenter observational case-control study
Tomonori Sekizaki, Hiraku Kameda, Hiroshi Nomoto, et al.
BMJ Open Diabetes Research & Care
|
November 15, 2022
Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study)
Hiroshi Nomoto, Akihiro Takahashi, Akinobu Nakamura, et al.
Japanese Journal of Ophthalmology
|
May 10, 2025
Factors predictive of treatment outcomes in submacular hemorrhage secondary to age-related macular degeneration
Yuto Watanabe, Takashi Koto, Aya Takahashi, et al.
Cancer Research
|
October 4, 2018
HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNA
Wenwen Wu, Nana Rokutanda, Jun Takeuchi, et al.
Page
of 13